You just read:

Immune-Oncology Market is Anticipated to Rise at a Significant CAGR Owing to Increase in R&D to Develop Anti-Cancer Drugs Till 2022: Radiant Insights, Inc.

News provided by

Radiant Insights, Inc.

Apr 02, 2019, 06:20 ET